RedDress

Regenerative Wound Care Technology

Health Tech & Life Sciences
Active
Series D Pardes Hanna-Karkur, Israel Founded 2009
Website ↗ LinkedIn
Last updated 2026-06-18
Total raised
$42.5M
Last: 2024-07
Stage
Series D
Founded
2009
Headcount
33
HQ
Pardes Hanna-Karkur, Israel
Sector
Health Tech & Life Sciences

About

RedDress is the developer of ActiGraft, an FDA-cleared regenerative wound care solution based on the companys proprietary patented technology for reproducing the bodys natural ability to heal wounds. ActiGraft enables healthcare providers to produce, in real-time, in vitro blood clots from a patients whole blood. Once applied, the blood clots serve as a protective covering, biologic scaffold, and wound microenvironment to help promote the bodys natural wound-healing processes.

Funding history · 4 rounds · $42.5M total

2024-07
2023-05
2020-05
2020-01

Q&A

What is RedDress's primary product?
RedDress develops ActiGraft, an FDA-cleared regenerative wound care solution that uses a patient's whole blood to produce in vitro blood clots, which then promote natural wound-healing processes.
Where is RedDress headquartered?
RedDress is headquartered in Pardes Hanna-Karkur, Israel, with an additional office in Ponte Vedra Beach, FL, USA.
What is RedDress's employee count?
RedDress has 33 employees, which falls into the 11-50 employee bucket.
When was RedDress founded?
RedDress was founded in April 2009.
What is the total amount of funding RedDress has raised to date?
RedDress has raised a total of $42,500,000 USD in funding.
When did RedDress complete its most recent funding round?
RedDress completed a funding round in July 2024, with Katao Venture Partners participating.
Which investors participated in RedDress's May 2023 funding round?
In May 2023, RedDress secured funding with participation from Athoss and HCS Capital.
What is RedDress's current funding stage?
RedDress is currently in its Series D funding stage.

Team · 1

Igal Kushnir
Founder · Founder & Medical Director
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2B2CB2BB2C

Highlights

1 Patents

Tags

pain-reliefhealthcare-providersdiabeteschronic-painmedical-devicesregenerative-medicinemedical-technologies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)